Premium
Erythromycin shortens orocaecal transit time in diabetic male subjects : a double‐blind placebo‐controlled study
Author(s) -
MINOCHA A.,
KATRAGADDA R.,
RAHAL P. S.,
RIES† A.
Publication year - 1995
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.1995.tb00416.x
Subject(s) - erythromycin , placebo , lactulose , medicine , gastroenterology , crossover study , flatulence , postprandial , diabetes mellitus , endocrinology , chemistry , antibiotics , biochemistry , alternative medicine , pathology
SUMMARY Background : The effects of erythromycin on small bows motility are controversial. Orocaecal transit time (OCTT) is considered to be a valid measure of small bowel motility. Methods : We studied the effect of erythromycin on OCTT in diabetic male subjects in a double‐blind placebo‐controlled crossover fashion. After an overnight fast, subjects received erythromycin 500 mf 250 mg or placebo, on 3 different days. A standard solid meal containing 20 g lactulose was administered 30 min after the erythromycin ingestion. Exhaled breath was collected and hydrogen concentration was assessed over 5 h. Breath hydrogen concentrations for each session were analysed over time by a generalized logistic function generating a sigmoidal curve. Front transit time was recorded as the time point when a sustained rise in breath hydrogen concentration of at least 5 p.p.m. was first observed. Results : The mean ± S.E.M. time taken for the front of the meal to reach the caecum was 92.5 ± 9.5, 86.1±16.5 and 62.3 ± 12.1 min for placebo, erythromycin 250 mg and erythromycin 500 mg, respectively. The OCTT was significantly decreased with erythromycin 500 mg compard to placebo ( P < 0.05). Conclusion : Oral administration of 500 mg erythromycin has prokinetic effect on orocaecal transit in male patients with diabetes mellitus.